Healthcare >> Sector Roundtables >> November 1, 1999

Roundtable Forum: Biotechnology Industry

WILLIAM SLATTERY is a Partner at Deerfield Management Company covering the biotechnology and healthcare based Internet technologies. He began his career at the laboratory bench, studying complications associated with End Stage Renal Disease. Mr. Slattery was previously associated with Amerindo Investment Advisors, Inc., National Medicine Enterprises, Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He received a BSc degree in Biochemistry from the State University of New York at Albany and attended the Graduate School of Health at Rutgers. Profile
MARGARET MALLOY is a Senior Analyst with Hambrecht & Quist. Previously, she was associated with Needhan & Company and PaineWebber. She also conducted research in the field of brain asymmetry and endocrinology at the University of Chicago. A Chartered Financial Analyst, Ms. Malloy holds a Bachelor's degree from the University of Chicago. Profile
JAY B. SILVERMAN is a Managing Director and Senior Research Analyst with Robertson Stephens, covering first-generation biotechnology companies and other emerging biopharmaceutical firms. Previously, he spent five years as a Vice President and Senior Analyst for biotechnology and medical technology with Schroder Wertheim & Company. Mr. Silverman holds a Bachelor's degree from the Wharton School of the University of Pennsylvania. Profile
ELISE T. WANG is currently a Managing Director in Equity Research at Salomon Smith Barney covering the biotechnology industry. Previously, she was a Managing Director and Senior Research Analyst in the Health Care Equity Research Group at PaineWebber Incorporated, covering the biotechnology industry. In 2000, Ms. Wang was voted runner-up in the Institutional Investor poll in Biotechnology. In addition, Ms. Wang also achieved recognition in the Wall Street Journal All Star Analyst survey in Biotechnology for the past three years. Prior to joining Equity Research at PaineWebber in January of 1996, she was a Vice President in the Health Sciences Group of the Investment Banking Division of PaineWebber with responsibility for providing financial advisory work and services in biotechnology and other healthcare sectors. Ms. Wang holds a Bachelor of Arts degree in Engineering Sciences with a specialty in Biomechanics from Harvard University and a Master of Business Administration degree from Harvard Graduate School of Business. Profile
TWST: Were you surprised by the performance of the biotechnology stocks

in 1999?

Ms. Wang: It certainly has been a terrific year. According to the

indices we track, the sector is up about 40%.